| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |